pDIFFIR: Geriatric Periprosthetic DIstal Femur: FIxation Versus Replacement
Launched by UNITY HEALTH TORONTO · Mar 28, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
The pDIFFIR clinical trial is studying two different treatment options for elderly patients who have suffered a specific type of knee fracture called a periprosthetic distal femur fracture. This type of fracture occurs around a knee joint that has already been replaced with an artificial implant. The trial will compare two approaches: one involves using surgical methods to fix the broken bone with plates, nails, and screws, while the other option is to replace the knee joint entirely with a new artificial knee. The main goal is to see which method helps reduce knee pain and improves the ability to move around after surgery.
To participate in this study, individuals must be 65 years or older and have an acute fracture that occurred within a week of the injury. They should have been able to walk independently or with assistance before the injury. Participants will be monitored for various outcomes, including pain levels, overall health, and quality of life. The study aims to enroll 148 patients, and it's currently looking for participants. It's important to note that certain conditions, like infections or previous knee surgeries, may exclude someone from joining the trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • 65 years and older
- • Isolated periprosthetic fracture of the distal femur around a stable primary total knee arthroplasty (Lewis and Rorabeck Type 1-2)
- • Fracture is acute (within 1 week from time of injury)
- • Patient was ambulatory (with or without walking aids) in the community and at home prior to the injury
- • Independent or moderately frail with score of 3 to 6 on the validated Clinical Frailty Scale
- • Patient is able to read and understand the consent form document, or an interpreter is available to the patient at the time of consent and follow-up
- • Patient or substitute decision maker is able to provide written informed consent to participate in the study
- Exclusion Criteria:
- • • Active infection around the fracture (soft tissue or bone)
- • Open fracture
- • Bilateral femur fractures
- • Major neuro-vascular injury requiring intervention, compartment syndrome and major neurologic injuries
- • Pathological fracture excluding osteoporosis
- • Ipsilateral total knee arthroplasty using revision components (varus/valgus constraint, stemmed femoral components)
- • Periprosthetic distal femur fracture around a loose or failing primary total knee arthroplasty (Lewis and Rorabeck Type III)
- • Ipsilateral primary partial knee or patellofemoral arthroplasty
- • Previous ORIF of the distal femur or proximal tibia or patella
- • Current or previous extensor mechanism (patellar tendon, quadriceps tendon, or patella fracture) disruption or repair
- • Poly-trauma status (Injury Severity Score\>15) or any associated major injuries of the lower extremities that may hinder post-operative ambulation
- • Medical contraindication to surgery
About Unity Health Toronto
Unity Health Toronto is a leading healthcare organization dedicated to providing exceptional patient care, advancing medical research, and fostering education in the field of health sciences. Comprising St. Michael's Hospital, St. Joseph's Health Centre, and Providence Healthcare, Unity Health integrates a diverse range of clinical services and innovative research initiatives. The organization is committed to improving health outcomes through collaborative partnerships and community engagement, while upholding the highest standards of ethics and integrity in its clinical trials and research endeavors. By focusing on patient-centered approaches, Unity Health Toronto aims to drive advancements in healthcare and contribute to the well-being of the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Amir Khoshbin, MD
Principal Investigator
Unity Health Toronto - St Michael's Hospital
Jesse Wolfstadt, MD
Principal Investigator
Mount Sinai Health Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials